Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3217
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03128866 | Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery | ||
| NCT00528502 | Lidocaine Supplement for Minimal Invasive Parathyroid Surgery | ||
| NCT04633902 | Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation | ||
| NCT03541902 | Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma | ||
| NCT03263572 | Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia | ||
| NCT01808677 | Registry Study of Thoracic Reirradiation for Non-Small Cell Lung Cancer (NSCLC) Utilizing Proton Beam Therapy or Intensity Modulated Radiation Therapy | ||
| NCT01208662 | Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 | ||
| NCT06257888 | A Prospective Cohort With Patient Navigation as an Intervention for Breast Cancer Patients | ||
| NCT04404088 | Acalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicular Lymphoma | ||
| NCT01090388 | Bladder Cancer Patient-Reported Outcomes | ||
| NCT00515788 | DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis | ||
| NCT04132505 | Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer | ||
| NCT02018653 | CASAD for Severe Diarrhea in the Emergency Department | ||
| NCT02530437 | Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer | ||
| NCT07136077 | A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy | ||
| NCT03070301 | A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors | ||
| NCT01750983 | Ipilimumab and Lenalidomide in Advanced Cancer | ||
| NCT04047641 | Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome | ||
| NCT00458354 | Use of Spinal Sealant System During Spinal Surgery | ||
| NCT00221039 | Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A | ||
| NCT06815354 | Comprehensive Assessment of Cancer Theranostic Response | ||
| NCT02295956 | Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer | ||
| NCT03367156 | Dexamethasone in Controlling Dyspnea in Patients With Cancer | ||
| NCT00500422 | Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients | ||
| NCT02167295 | Biobehavioral and Cultural Determinants of Betel Quid Chewing, Dependence, and Withdrawal in Taiwan | ||
| NCT00980239 | HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver | ||
| NCT00448019 | FCR and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL) | ||
| NCT01073267 | Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides | ||
| NCT05761951 | Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer | ||
| NCT00510653 | Gleevec Study for Patients With Ovarian Cancer | ||
| NCT00511641 | Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer | ||
| NCT04751422 | Medical Data Collection for the Evaluation of Radiofrequency Ablation and Cement Augmentation for the Treatment of Secondary Metastases to the Spine | ||
| NCT00529022 | Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer | ||
| NCT00533338 | Weight Gain Prevention for Breast Cancer Survivors | ||
| NCT00566618 | Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis | ||
| NCT00003048 | Amifostine in Treating Patients With Myelodysplastic Syndrome | ||
| NCT05053555 | High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies | ||
| NCT02861417 | Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant | ||
| NCT02043158 | Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer | ||
| NCT02096055 | Guadecitabine With or Without Idarubicin or Cladribine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia | ||
| NCT02891447 | Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer | ||
| NCT02394535 | Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer | ||
| NCT00502125 | In Vivo Confocal Imaging of Oral Mucosa | ||
| NCT00429117 | Interest in Spirituality and Oncology: Is It An International Phenomenon? | ||
| NCT01375140 | Ruxolitinib and Lenalidomide for Patients With Myelofibrosis | ||
| NCT06548230 | A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) | ||
| NCT03587662 | Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer | ||
| NCT03207542 | Trial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory B-cell or T-cell Precursor Acute Lymphoblastic Leukemia (ALL) | ||
| NCT01952054 | Denosumab for Breast Cancer With Bone Mets | ||
| NCT03136146 | Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia |
